Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cantonetti

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Acta Dermato-Venereologica|September 18, 2001
Systemic therapy of primary cutaneous B-cell lymphoma, marginal zone type, with rituximab, a chimeric anti-CD20 monoclonal antibodyR Soda, A Costanzo, M Cantonetti, et al.
European Journal of Haematology|March 1, 1989
Intermediate-dose (25 mg/m2) intravenous melphalan for patients with multiple myeloma in relapse or refractory to standard treatmentM T Petrucci, G Avvisati, M Tribalto, et al.
European Journal of Haematology|February 1, 1992
Multiple skin tumors in long-term treatment with hydroxyureaR Stasi, M Cantonetti, E Abruzzese, et al.
Italian Journal of Neurological Sciences|October 1, 1991
Non-Hodgkin lymphomas of the central nervous systemF Pisani, M Antimi, M Cantonetti, et al.
Journal of Chemotherapy (Florence, Italy)|December 1, 1989
Ceftriaxone plus amikacin in a single daily dose as empiric antibiotic therapy in granulocytopenic patientsL Cudillo, M Masi, M T Scimò, et al.
Leukemia Research|March 15, 2001
New reciprocal translocation t(6;10) (q27;q11) associated with idiopathic myelofibrosis and eosinophiliaM C Cox, P Panetta, A Venditti, et al.
Acta Dermato-Venereologica|October 4, 2002
Disseminated pagetoid reticulosis presenting as cytotoxic CD4/CD8 double negative cutaneous T-cell lymphomaG Pagnanelli, L Bianchi, M Cantonetti, et al.
Haematologica|September 1, 1990
Peripheral polyneuropathy during treatment with alpha-2 interferonL Cudillo, M Cantonetti, A Venditti, et al.
Recenti Progressi in Medicina|September 1, 1992
[Recent biological and therapeutic advances in multiple myeloma]U Coppetelli, G Avvisati, M Tribalto, et al.
Pharmacological Research|January 18, 2006
O6-(4-bromothenyl)guanine (PaTrin-2), a novel inhibitor of O6-alkylguanine DNA alkyl-transferase, increases the inhibitory activity of temozolomide against human acute leukaemia cells in vitroM Turriziani, P Caporaso, L Bonmassar, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Acta Dermato-Venereologica|September 18, 2001
Systemic therapy of primary cutaneous B-cell lymphoma, marginal zone type, with rituximab, a chimeric anti-CD20 monoclonal antibodyR Soda, A Costanzo, M Cantonetti, et al.
European Journal of Haematology|March 1, 1989
Intermediate-dose (25 mg/m2) intravenous melphalan for patients with multiple myeloma in relapse or refractory to standard treatmentM T Petrucci, G Avvisati, M Tribalto, et al.
European Journal of Haematology|February 1, 1992
Multiple skin tumors in long-term treatment with hydroxyureaR Stasi, M Cantonetti, E Abruzzese, et al.
Italian Journal of Neurological Sciences|October 1, 1991
Non-Hodgkin lymphomas of the central nervous systemF Pisani, M Antimi, M Cantonetti, et al.
Journal of Chemotherapy (Florence, Italy)|December 1, 1989
Ceftriaxone plus amikacin in a single daily dose as empiric antibiotic therapy in granulocytopenic patientsL Cudillo, M Masi, M T Scimò, et al.
Leukemia Research|March 15, 2001
New reciprocal translocation t(6;10) (q27;q11) associated with idiopathic myelofibrosis and eosinophiliaM C Cox, P Panetta, A Venditti, et al.
Acta Dermato-Venereologica|October 4, 2002
Disseminated pagetoid reticulosis presenting as cytotoxic CD4/CD8 double negative cutaneous T-cell lymphomaG Pagnanelli, L Bianchi, M Cantonetti, et al.
Haematologica|September 1, 1990
Peripheral polyneuropathy during treatment with alpha-2 interferonL Cudillo, M Cantonetti, A Venditti, et al.
Recenti Progressi in Medicina|September 1, 1992
[Recent biological and therapeutic advances in multiple myeloma]U Coppetelli, G Avvisati, M Tribalto, et al.
Pharmacological Research|January 18, 2006
O6-(4-bromothenyl)guanine (PaTrin-2), a novel inhibitor of O6-alkylguanine DNA alkyl-transferase, increases the inhibitory activity of temozolomide against human acute leukaemia cells in vitroM Turriziani, P Caporaso, L Bonmassar, et al.
Pageof 4